Content is Still the King in Pharma Marketing

Content is Still the King in Pharma Marketing

Digital Transformation is helping pharmaceutical industry to revisit its business model, to improve processes, and to deliver an authentic customer experience to HCPs in their journey. Companies are now focusing on omnichannel engagement, data driven insights, responsiveness and personalization towards patients and doctors. However, Technology is an Enabler, not a Strategy in itself. It just helps companies to…
Turbocharging Pharma Marketing through Doctor Networks

Turbocharging Pharma Marketing through Doctor Networks

Product managers and marketers in the pharma industry have spent huge amounts of resources over email marketing, AdSense, and Facebook marketing with an objective to bring doctors to their website. Some have also launched mobile apps and propriety websites only to abandon them midway in absence of any traction between the doctors’ community. A majority,…
ROI on Webinars for Doctors

ROI on Webinars and Online Events for Doctors

Dive deeper to understand the ROI on Webinars and Online Events Globally, doctors are a busy tribe and getting them involved in any offline activity is becoming challenging every day. The COVID-19 pandemic has made it even harder. Time is a resource which is scarce and valued highly by busy medical professionals. Make no mistake,…
Insights on Lung Cancer Treatment

Neoadjuvant Chemotherapy and Ipilimumab For Stage II-IIIA Non-Small Cell Lung Cancer

Objective of this Therapy Area Insight Immune therapy is increasingly becoming an effective treatment for non-small cell lung cancer (NSCLC). The Objective of this study is to determine the percentage of early stage NSCLC patients with detectable circulating T cells specific against tumor-associated antigen (TAA) after receiving platinum based neoadjuvant chemotherapy plus ipilimumab before surgery.…
Subscribe to MedSynapse Insights News Letter

Never miss an insight from us. We'll email you when new articles are published on this topic.